106 related articles for article (PubMed ID: 7910542)
1. The visualization of granulomatous disease with somatostatin receptor scintigraphy.
Oztürk E; Günalp B; Ozgüven M; Ozkan S; Sipit T; Narin Y; Bayhan H
Clin Nucl Med; 1994 Feb; 19(2):129-32. PubMed ID: 7910542
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogue scintigraphy in granulomatous diseases.
Vanhagen PM; Krenning EP; Reubi JC; Kwekkeboom DJ; Bakker WH; Mulder AH; Laissue I; Hoogstede HC; Lamberts SW
Eur J Nucl Med; 1994 Jun; 21(6):497-502. PubMed ID: 8082663
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis.
Lebtahi R; Crestani B; Belmatoug N; Daou D; Genin R; Dombret MC; Palazzo E; Faraggi M; Aubier M; Le Guludec D
J Nucl Med; 2001 Jan; 42(1):21-6. PubMed ID: 11197973
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor imaging in patients with sarcoidosis.
Kwekkeboom DJ; Krenning EP; Kho GS; Breeman WA; Van Hagen PM
Eur J Nucl Med; 1998 Sep; 25(9):1284-92. PubMed ID: 9724378
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
[TBL] [Abstract][Full Text] [Related]
6. Sarcoidosis in a clinically unaffected joint demonstrated by somatostatin receptor scintigraphy.
Kroot EJ; Dolhain RJ; van Hagen PM; Kwekkeboom DJ
Clin Nucl Med; 2006 Aug; 31(8):501-3. PubMed ID: 16855445
[No Abstract] [Full Text] [Related]
7. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
[TBL] [Abstract][Full Text] [Related]
8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.
Kwekkeboom DJ; Krenning EP; Scheidhauer K; Lewington V; Lebtahi R; Grossman A; Vitek P; Sundin A; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):184-9. PubMed ID: 19713709
[No Abstract] [Full Text] [Related]
9. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
Jamar F; Fiasse R; Leners N; Pauwels S
J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
[TBL] [Abstract][Full Text] [Related]
11. False-positive somatostatin receptor scintigraphy due to an accessory spleen.
Lebtahi R; Cadiot G; Marmuse JP; Vissuzaine C; Petegnief Y; Courillon-Mallet A; Cattan D; Mignon M; Le Guludec D
J Nucl Med; 1997 Dec; 38(12):1979-81. PubMed ID: 9430481
[TBL] [Abstract][Full Text] [Related]
12. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.
Kahaly G; Diaz M; Hahn K; Beyer J; Bockisch A
J Nucl Med; 1995 Apr; 36(4):550-4. PubMed ID: 7699440
[TBL] [Abstract][Full Text] [Related]
13. [Receptor scintigraphy using 111In-pentetreotide in endocrine gastroenteropancreatic tumors].
Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Benning R; Neuhaus C; Lenze H; Trautmann ME; Arnold R
Nuklearmedizin; 1993 Dec; 32(6):299-305. PubMed ID: 7905200
[TBL] [Abstract][Full Text] [Related]
14. Expression of somatostatin receptors in inflammatory lesions and diagnostic value of somatostatin receptor scintigraphy in patients with ANCA-associated small vessel vasculitis.
Neumann I; Mirzaei S; Birck R; Osinger K; Waldherr R; Köhn HD; Meisl FT
Rheumatology (Oxford); 2004 Feb; 43(2):195-201. PubMed ID: 12949255
[TBL] [Abstract][Full Text] [Related]
15. The radiology of sarcoidosis.
Clarke D; Mitchell AW; Dick R; James GD
Sarcoidosis; 1994 Sep; 11(2):90-9. PubMed ID: 7809502
[TBL] [Abstract][Full Text] [Related]
16. [Phase III additional clinical study of 111In-pentetreotide (MP-1727): diagnosis of gastrointestinal hormone producing tumors based on the presence of somatostatin receptors].
Saga T; Tamaki N; Itoi K; Yamazaki T; Endo K; Watanabe G; Maruno H; Machinami R; Koizumi K; Ichikawa T; Takami H; Ishibashi M; Kubo A; Kusakabe K; Hirata Y; Murata Y; Miyachi Y; Tsubuku M; Sakahara H; Katada K; Tonami N; Yamamoto K; Konishi J; Imamura M; Doi R; Shimatsu A; Noguchi S; Hasegawa Y; Ishikawa O; Watanabe Y; Nakajo M
Kaku Igaku; 2003 May; 40(2):185-203. PubMed ID: 12884785
[TBL] [Abstract][Full Text] [Related]
17. 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
Weinmann P; Crestani B; Tazi A; Genereau T; Mal H; Aubier M; Valeyre D; Moretti JL; Le Guludec D; Lebtahi R
J Nucl Med; 2000 Nov; 41(11):1808-12. PubMed ID: 11079487
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonoscintigraphy in sarcoidosis and certain forms of pulmonary tuberculosis].
Palamarchuk VP; Kostina ZI; Vlasova MM
Med Radiol (Mosk); 1985 Sep; 30(9):37-40. PubMed ID: 4046777
[TBL] [Abstract][Full Text] [Related]
19. Visualization of Paget's disease during somatostatin receptor scintigraphy.
Kang S; Mishkin FS
Clin Nucl Med; 1999 Nov; 24(11):900-2. PubMed ID: 10551483
[No Abstract] [Full Text] [Related]
20. Indium-111-labeled leukocyte scintigraphy in a case of cutaneous sarcoidosis.
Miyazaki C; Tsuchiya K; Itoh K
J Nucl Med; 1993 May; 34(5):812-4. PubMed ID: 8478716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
